CBD and Antibiotic Resistance

Peer-reviewed studies into the potential effects of Cannabidiol and Antibiotic Resistance

On this page, CBD and Antibiotic Resistance, you will find research pertaining to the use of Cannabidiol and Cannabinoids and its possible effects on Antibiotic Resistance. The information below is not meant to influence your opinion, but rather give you access to a wealth of scientific literature in an attempt to make and educated and informed choice. Click Here to see all of the conditions that have been researched alongside CBD and Antibiotic Resistance. If you have any questions pertaining to the research, please email us at info@hempicated.com.

Antibacterial cannabinoids from Cannabis sativa: a structure-activity study

From the abstract:

All five major cannabinoids (cannabadiol (1b), cannabichromene (2), cannabigerol (3b), Delta (9)- tetrahydrocannabinol (4b), and cannabinol (5)) showed potent activity against a variety of methicillin-resistant Staphylococcus aureus (MRSA) strains of current clinical relevance.

Antibacterial activity of delta9-tetrahydrocannabinol and cannabidiol.

From the abstract:

The minimum inhibiting concentrations (MIC) of delta9-tetrahydrocannabinol (THC) and cannabidiol (CBD) for staphylococci and streptococci in broth are in the range of 1-5 mug/ml. In the same range, both compounds are also bactericidal.